The National Comprehensive Cancer Network (NCCN) guidelines recommend a multigene panel test for all individuals with a diagnosis of CRC below the age of 50 years, regardless of somatic MMR gene status [31]. The gene discussed is MRC1; the disease is colorectal carcinoma.